Biochemical Alterations of Stored Erythrocyte Membranes
NCT02639780 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2022-01-04
Summary
The investigators will define procoagulant properties of packed red blood cells and investigate whether packed red blood cells from certain donor populations are prone to induce procoagulant states.
Conditions
- Coagulation
Interventions
- OTHER
-
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
Sponsors & Collaborators
-
Medical Scientific Fund of the Mayor of Vienna
collaborator OTHER -
European Society of Anaesthesiology
collaborator OTHER -
Medical University of Vienna
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2019-11-30
- Completion
- 2021-12-31
Countries
- Austria
Study Locations
More Related Trials
-
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
NCT05881798 ·Status: RECRUITING
-
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NCT05301348 ·Status: RECRUITING ·Phase: NA
-
Heparin for Pregnant Women With Thrombophilia
NCT01019655 ·Status: UNKNOWN ·Phase: PHASE3
-
Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed
NCT02565836 ·Status: COMPLETED
-
tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden
NCT04248868 ·Status: COMPLETED ·Phase: PHASE3
-
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
NCT00056550 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombin Generation as a New Test for Anticoagulation Management in Patients With ECMO
NCT03832842 ·Status: COMPLETED
-
Anticoagulant Therapy During Pacemaker Implantation
NCT00479362 ·Status: COMPLETED ·Phase: PHASE4
-
Antithrombin Supplementation in ECMO
NCT03208270 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants
NCT03296982 ·Status: COMPLETED
-
Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)
NCT02321917 ·Status: COMPLETED ·Phase: NA
-
Are Uterine Fibroids Pro-thrombotic?
NCT05607602 ·Status: ACTIVE_NOT_RECRUITING
-
Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-
NCT02862366 ·Status: COMPLETED
-
Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients
NCT04412304 ·Status: COMPLETED
-
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage
NCT06974396 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients
NCT03090893 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
NCT02600260 ·Status: COMPLETED ·Phase: NA
-
Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
NCT06429787 ·Status: RECRUITING
-
Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis
NCT06209892 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
NCT00625248 ·Status: COMPLETED
-
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications
NCT00603148 ·Status: COMPLETED
-
Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots
NCT03537521 ·Status: WITHDRAWN
-
Registry of Patients Prescribed Anticoagulation
NCT03504007 ·Status: RECRUITING
-
Von Willebrand Factor Concentrate During ECMO Support
NCT03613584 ·Status: UNKNOWN ·Phase: PHASE2
-
Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit.
NCT02966080 ·Status: WITHDRAWN ·Phase: NA